
M42, AstraZeneca, and SOPHiA GENETICS Launch Groundbreaking Liquid Biopsy Initiative in UAE to Advance Cancer Diagnosis and Care
M42, a global health leader driven by advanced technology, continues to lead the way in artificial intelligence and clinical innovation as part of its mission to transform healthcare in the UAE and beyond. In a significant step forward for precision oncology, M42 has announced a strategic collaboration with AstraZeneca and